Trial intelligence / Profile preview

Brain Morphometry in Knee OA Treated With Duloxetine

NCT02903238Completed

Sponsor
Northwestern University
Start
Jul 2011
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Single-blind trial of duloxetine in osteoarthritis (OA), sponsored by Northwestern University. Primary endpoint: Brain Regional Gray Matter Density at 2 weeks. Started Jul 2011; status: completed.

02

Drugs

duloxetine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02903238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02903238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call